Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-01-11
2005-01-11
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S325000, C435S377000, C435S375000, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
06841542
ABSTRACT:
The invention relates to TGF-β blocking agent-treated HSC compositions and methods comprising the same. The TGF-β blocking agent-treated stem cells are viable for an extended time in culture without replication or differentiation and upon transfer to appropriate conditions are capable of long term hematopoietic reconstitution.
REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5958774 (1999-09-01), Klein et al.
Written Opinion mailed Oct. 30, 2002, from IPA/US, Commissioner of Patents and Trademarks, for Int'l. application No. PCT/US01/21420; Int'l. Filing Date: Jul. 6, 2001.
Batard, P., et al., “TGF-β1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation,”Journal of Cell Science,113:383-390 (2000).
Fortunel, N., et al., “Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis,”Blood, 95:(6) 2022-2036 (2000).
Hatzfeld, J., et al., “Release of Early Human Hematopoietic Progenitors from Quiescence by Antisense Transforming Growth Factor β1 or Rb Oligonucleotides,”J. Exp. Med., 174:925-929 (1991).
Hudziak, R.M., et al., “Antiproliferative Effects of Steric Blocking Phosphorodiamidate Morpholino Antisense Agents Directed against c-myc,”Antisense and Nucleic Acid Drug Development, 10:163-176 (2000).
Hudziak, R.M., et al., “Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation,”Antisense and Nucleic Acid Drug Development, 6:267-272 (1996).
Summerton, J., et al., “Morpholino Antisense Oligomers: Design, Preparation, and Properties,”Antisense and Nucleic Acid Drug Development, 7:187-195 (1997).
Bartelmez Stephen H.
Iversen Patrick L.
AVI BioPharma Inc.
McGarry Sean
Perkins Coie LLP
LandOfFree
Transforming growth factor beta (TGF-β) blocking... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transforming growth factor beta (TGF-β) blocking..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transforming growth factor beta (TGF-β) blocking... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3384731